Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GRDN · against 358 other Healthcare companies of similar size
Ranked #196 of 359 · scores higher than 46% of peers · safety percentile 49
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)37 peers with a safety percentile of 40–49, including GRDN · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GRDN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 343 reported | 0.15× | 0.22× | 58% | 33% | |
| BetaLower is better · 342 reported | 0.02 | 0.57 | 90% | 33% | |
| Current ratioHigher is better · 345 reported | 1.65× | 2.82× | 27% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 2.6B USD | 100 | 43 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 1.8B USD | 99 | 42 | |
| 5 | 2.2B USD | 99 | 48 | |
| 192 | 423.1B JPY (≈$2.9B) | 50 | 65 | |
| 193 | 2.4B USD | 49 | 64 | |
| 194 | 5.24T KRW (≈$3.8B) | 49 | 60 | |
| 195 | 13.2B CNY (≈$1.9B) | 49 | 52 | |
| 196 | 2.6B USD | 49 | 66 | |
| 197 | 9.4B CNY (≈$1.3B) | 48 | 28 | |
| 198 | 21.3B HKD (≈$2.7B) | 48 | 68 | |
| 199 | 212.3B JPY (≈$1.4B) | 47 | 62 | |
| 200 | 14.8B BRL (≈$2.7B) | 47 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score